CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks. Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
Open platformOpen platform

China Sunsine Chemical Q3 revenue jumps 79% on higher prices and volumes

By Reuters News


Overview

  • Specialty chemical producer's Q3 sales revenue rose 79%r, driven by higher prices and volumes

  • Quarterly profit after tax more than doubled year-on-year

  • Company's 20,000-tonne annual Weifang production project commenced commercial production


Outlook

  • Company expects continued volatility in raw material prices and selling prices due to global uncertainty

  • Company says oversupply and intense competition in China's rubber chemicals industry persist

  • Annual production capacity projected to rise to 272,000 tonnes in FY2026 and FY2027


Result Drivers

  • VOLUME GROWTH - Sales volume reached a record high, up 22% year-on-year

  • HIGHER SELLING PRICES - Co said average selling price rose 47% mainly due to higher prices of raw materials

  • MARGIN GAINS - Gross margin rose 6.4 pts to 27.3%


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Gross Margin

27.30%

Q3 Sales revenue

RMB 1.37 bln

Q3 Profit

RMB 201.3 mln


Analyst Coverage

  • The one available analyst rating on the shares is "hold"

  • The average consensus recommendation for the specialty chemicals peer group is "buy."

  • Wall Street's median 12-month price target for China Sunsine Chemical Holdings Ltd is S$0.71, about 12.7% above its November 12 closing price of S$0.63

  • The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 8 three months ago


Reuters Recommended Reads

  • Nov 10 - Persil-maker Henkel targets top end of 2026 sales forecast range

  • Nov 12 - German chemicals lobby lifts 2026 sales forecast, but warns recovery remains elusive

  • Nov 10 - Israel's ICL Group Q3 sales, net income rise on diversified portfolio


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.